# BIOCRYST PHARMACEUTICALS INC > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:be26b53a-06cc-4d38-8d54-d554af457f39 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/biocryst-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-15T04:45:54.5749+00:00 | | Last reviewed | 2026-10-15T04:45:54.5749+00:00 | ## Identity - Legal name: BIOCRYST PHARMACEUTICALS INC - Display name: BIOCRYST PHARMACEUTICALS INC ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T00:46:43.620251+00:00 | | Completeness | 0.409 | | Record Quality | 0.834 | | Directors | 12 | | Committees | 1 | | Governance events | 10 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - A. Machelle Sanders: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:6 - Alan G. Levin: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:7 - Amy E. McKee: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:8 - Jill C. Milne: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-01-01. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:11 - Jon P. Stonehouse: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2007-01-01. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:13 - Steven R. Frank: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:15 - Theresa M. Heggie: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:16 - Amy E. McKee, M.D.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:9 - Charles K. Gayer: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:10 - Jill C. Milne, Ph.D.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:12 - Steven K. Galson, M.D., MPH: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:14 - Vincent J. Milano: Chair of the Board. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:5 ## Committees - Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: Charles K. Gayer (member, unknown). committee_id=alpha:committee:biocryst-pharmaceuticals-inc:chief-executive-officer-and-director ## Executive leadership - Anthony J. Doyle: Chief Financial Officer (resigned effective April 9, 2025) [CFO]. Status: current. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:18 - Helen M. Thackray: Chief Research and Development Officer (resigned effective September 1, 2025). Status: current. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:21 - Jon P. Stonehouse: Chief Executive Officer (retired effective December 31, 2025) [CEO]. Status: current. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:22 - Alane P. Barnes: Chief Legal Officer and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:17 - Babar Ghias: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:19 - Charles K. Gayer: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:20 - Ronald S. Dullinger: Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:23 - Sandeep M. Menon: Chief Research and Development Officer. Status: unknown. claim_id=alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:24 ## Governance events - CFO_CHANGED: Anthony J. Doyle executive of BIOCRYST PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-15T04:45:54.5749+00:00. event_id=alpha:event:transition:40zuq3reck7b - EXECUTIVE_APPOINTED: Helen M. Thackray executive of BIOCRYST PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-15T04:45:54.5749+00:00. event_id=alpha:event:transition:1cfchji1k5z3hs - CEO_CHANGED: Jon P. Stonehouse executive of BIOCRYST PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-15T04:45:54.5749+00:00. event_id=alpha:event:transition:1nfwzcp16rm3wd - DIRECTOR_APPOINTED: Jill C. Milne seat on BIOCRYST PHARMACEUTICALS INC, effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-15T04:45:54.5749+00:00. event_id=alpha:event:transition:1eh9o6kziv6ws - DIRECTOR_APPOINTED: Steven R. Frank seat on BIOCRYST PHARMACEUTICALS INC, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-15T04:45:54.5749+00:00. event_id=alpha:event:transition:2vmv719s7xf3 - DIRECTOR_APPOINTED: A. Machelle Sanders seat on BIOCRYST PHARMACEUTICALS INC, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-15T04:45:54.5749+00:00. event_id=alpha:event:transition:1v3vf541kwypoi - DIRECTOR_APPOINTED: Amy E. McKee seat on BIOCRYST PHARMACEUTICALS INC, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-15T04:45:54.5749+00:00. event_id=alpha:event:transition:1vfluot1q7g7ev - DIRECTOR_APPOINTED: Alan G. Levin seat on BIOCRYST PHARMACEUTICALS INC, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-15T04:45:54.5749+00:00. event_id=alpha:event:transition:d4wt4v1jgjjhd - DIRECTOR_APPOINTED: Theresa M. Heggie seat on BIOCRYST PHARMACEUTICALS INC, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-15T04:45:54.5749+00:00. event_id=alpha:event:transition:jgzamyr6hini - DIRECTOR_APPOINTED: Jon P. Stonehouse seat on BIOCRYST PHARMACEUTICALS INC, effective 2007-01-01. Effective: 2007-01-01. Detected: 2026-10-15T04:45:54.5749+00:00. event_id=alpha:event:transition:uz8lvf1gpssa1 ## Scoped resources - `alpha://company/biocryst-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record - `alpha://company/biocryst-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/biocryst-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/biocryst-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=board - `alpha://company/biocryst-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/biocryst-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/biocryst-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/biocryst-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/biocryst-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/biocryst-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/biocryst-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/biocryst-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/biocryst-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/biocryst-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/biocryst-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/biocryst-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/biocryst-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/biocryst-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/biocryst-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/biocryst-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=events - `alpha://company/biocryst-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/biocryst-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/biocryst-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Vincent J. Milano: Chair of the Board. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff2c963c10216d6b6625cbdc9a9478e311d8ae4e21868d3346247f2b7c247b0e. - A. Machelle Sanders: Director. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:6. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62588e45024ccb92806094a74f1d4bc41f819b0b6dfbee8832e869348099e434. - Alan G. Levin: Director. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62588e45024ccb92806094a74f1d4bc41f819b0b6dfbee8832e869348099e434. - Amy E. McKee: Director. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62588e45024ccb92806094a74f1d4bc41f819b0b6dfbee8832e869348099e434. - Amy E. McKee, M.D.: Director. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff2c963c10216d6b6625cbdc9a9478e311d8ae4e21868d3346247f2b7c247b0e. - Charles K. Gayer: President, Chief Executive Officer and Director. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff2c963c10216d6b6625cbdc9a9478e311d8ae4e21868d3346247f2b7c247b0e. - Jill C. Milne: Director. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:11. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62588e45024ccb92806094a74f1d4bc41f819b0b6dfbee8832e869348099e434. - Jill C. Milne, Ph.D.: Director. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff2c963c10216d6b6625cbdc9a9478e311d8ae4e21868d3346247f2b7c247b0e. - Jon P. Stonehouse: Director. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:13. Valid from: 2007-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62588e45024ccb92806094a74f1d4bc41f819b0b6dfbee8832e869348099e434. - Steven K. Galson, M.D., MPH: Director. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff2c963c10216d6b6625cbdc9a9478e311d8ae4e21868d3346247f2b7c247b0e. - Steven R. Frank: Director. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:15. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62588e45024ccb92806094a74f1d4bc41f819b0b6dfbee8832e869348099e434. - Theresa M. Heggie: Director. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:16. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62588e45024ccb92806094a74f1d4bc41f819b0b6dfbee8832e869348099e434. - Alane P. Barnes: Chief Legal Officer and Corporate Secretary. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff2c963c10216d6b6625cbdc9a9478e311d8ae4e21868d3346247f2b7c247b0e. - Anthony J. Doyle: Chief Financial Officer (resigned effective April 9, 2025). Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:18. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f7393b5fc4199fe3c1b04f421582b3df8884d0f0f7dc95cc0ab19569a2bdaa12. - Babar Ghias: Chief Financial Officer. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff2c963c10216d6b6625cbdc9a9478e311d8ae4e21868d3346247f2b7c247b0e. - Charles K. Gayer: President and Chief Executive Officer. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff2c963c10216d6b6625cbdc9a9478e311d8ae4e21868d3346247f2b7c247b0e. - Helen M. Thackray: Chief Research and Development Officer (resigned effective September 1, 2025). Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:21. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e8af5fb9ab5fab5deab6df656b5e929b98527748c060ed4c4df2dd1a91864835. - Jon P. Stonehouse: Chief Executive Officer (retired effective December 31, 2025). Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:22. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:58c1d0e0ca52d481a441af4667acb8c52440b342c633dbf6b0b3ed63494c26bc. - Ronald S. Dullinger: Chief Commercial Officer. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff2c963c10216d6b6625cbdc9a9478e311d8ae4e21868d3346247f2b7c247b0e. - Sandeep M. Menon: Chief Research and Development Officer. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff2c963c10216d6b6625cbdc9a9478e311d8ae4e21868d3346247f2b7c247b0e. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - BIOCRYST PHARMACEUTICALS INC. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8a029173ba0dde7d19882b0f0d79fbc41fb9452240c12ca695ebfc9e8e4881c0. ## Entity Status - Public listing published. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8a029173ba0dde7d19882b0f0d79fbc41fb9452240c12ca695ebfc9e8e4881c0. ## Published Fact - US. Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8a029173ba0dde7d19882b0f0d79fbc41fb9452240c12ca695ebfc9e8e4881c0. ## Security Listing - BCRX (NASDAQ). Claim: alpha:claim:company:be26b53a-06cc-4d38-8d54-d554af457f39:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8a029173ba0dde7d19882b0f0d79fbc41fb9452240c12ca695ebfc9e8e4881c0. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:8a029173ba0dde7d19882b0f0d79fbc41fb9452240c12ca695ebfc9e8e4881c0: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc). - alpha:projection-evidence:document:ff2c963c10216d6b6625cbdc9a9478e311d8ae4e21868d3346247f2b7c247b0e: [SEC DEF 14A 0001628280-26-026822](https://www.sec.gov/Archives/edgar/data/882796/000162828026026822/bcrx-20260423.htm). - alpha:projection-evidence:document:62588e45024ccb92806094a74f1d4bc41f819b0b6dfbee8832e869348099e434: [DEF 14A bcrx-20260423.htm](https://www.sec.gov/Archives/edgar/data/882796/000162828026026822/bcrx-20260423.htm). - alpha:projection-evidence:document:f7393b5fc4199fe3c1b04f421582b3df8884d0f0f7dc95cc0ab19569a2bdaa12: [BCRX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/882796/000162828026026822/bcrx-20260423.htm). - alpha:projection-evidence:document:e8af5fb9ab5fab5deab6df656b5e929b98527748c060ed4c4df2dd1a91864835: [BCRX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/882796/000162828026026822/bcrx-20260423.htm). - alpha:projection-evidence:document:58c1d0e0ca52d481a441af4667acb8c52440b342c633dbf6b0b3ed63494c26bc: [BCRX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/882796/000162828026026822/bcrx-20260423.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/biocryst-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/biocryst-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/biocryst-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/biocryst-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T00:46:43.410939+00:00; recorded 2026-10-16T00:46:43.410939+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.